Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles

Journal of Immunology

Volumn 163, Issue 3, 1999, Pages 1274-1281

  Martínez Lorenzo, María José ^a   Anel, Alberto ^a   Gamen, Susana ^a   Monleón, Inmaculada ^a   Lasierra, Pilar ^b   Larrad, Luis ^b   Piñeiro, Andrés ^a   Alava, María A ^a   Naval, Javier ^a  

^a UNIVERSITY OF ZARAGOZA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; LIGAND; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR;

ARTICLE; BLAST CELL; CELL DEATH; CELL STIMULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOREGULATION; LEUKEMIA CELL LINE; MEMBRANE VESICLE; MITOGENESIS; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; T LYMPHOCYTE ACTIVATION;

AMINO ACID SEQUENCE; ANTIGENS, CD95; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL-FREE SYSTEM; CYTOCHALASIN B; ENDOPEPTIDASES; FAS LIGAND PROTEIN; FLOW CYTOMETRY; HUMANS; HYDROLYSIS; JURKAT CELLS; LIGANDS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICROSCOPY, ELECTRON, SCANNING TRANSMISSION; MOLECULAR SEQUENCE DATA; PHYTOHEMAGGLUTININS; T-LYMPHOCYTES; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA; ULTRACENTRIFUGATION; VACUOLES;

EID: 0344731338     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Russell, J. H. 1995. Activation-induced death of mature T cells in the regulation of immune responses. Curr. Opin. Immunol. 7:382.
2. Dhein, J., H. Walczak, C. Bäumler, K. M. Debatin, and P. H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1 (Fas/CD95). Nature 373:438.
3. Brunner, T., R. J. Mogil, D. LaFace, N. J. Yoo, A. Mahboubi, F. Echeverri, S. J. Martin, W. R. Force, D. H. Lynch, C. F. Ware, et al. 1995. Cell-autonomous Fas(CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441.
4. Ju, S. T., D. J. Panka, H. Cui, R. Ettinger, M. El-Khatib, D. H. Sherr, B. Z. Stanger, and A. Marshak-Rothstein. 1995. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444.
5. Vignaux, F., and P. Golstein. 1994. Fas-based lymphocyte-mediated cytotoxicity against syngeneic activated lymphocytes: a regulatory pathway? Eur. J. Immunol. 24:923.
6. Alderson, M. R., T. W. Tough, T. Davis-Smith, S. Braddy, B. Falk, K. A. Schooley, R. G. Goodwin, C. A. Smith, F. Ramsdell, and D. H. Lynch. 1995. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181:71.
7. Singer, G. G., and A. K. Abbas. 1994. The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1:365.
8. Lynch, D. H., F. Ramsdell, and M. R. Alderson. 1995. Fas and FasL in the homeostatic regulation of immune responses. Immunol. Today 16:569.
9. Zheng, L., G. Fisher, R. E. Miller, J. Peschon, D. H. Lynch, and M. J. Lenardo. 1995. Induction of apoptosis in mature T cells by tumor necrosis factor. Nature 377:348.
10. Itoh, N., S. Yonehara, A. Ishii, M. Yonehara, S. I. Mizushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233.
11. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science 267:1449.
12. Suda, T., T. Takahashi, P. Golstein, and S. Nagata. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169.
13. Pitti, R. M., S. A. Marsters, S. Ruppert, C. J. Donahue, A. Moore, and A. Ashkenazi. 1996. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem. 271:12687.
14. Wiley, S. R., K. Schooley, P. J. Smolak, W. S. Din, C. P. Huang, J. K. Nicholl, G. R. Sutherland, T. D. Smith, C. Rauch, C. A. Smith, et al. 1995. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673.
15. Ashkenazi, A., and V. M. Dixit. 1998. Death receptors: signaling and modulation. Science 281:1305.
16. Martínez-Lorenzo, M. J., M. A. Alava, S. Gamen, J. K. Kim, A. Chuntharapai, A. Piñeiro, J. Naval, and A. Anel. 1998. Involvement of APO2 ligand/TRAIL in activation-induced death of Jurkat and human peripheral blood T cells. Eur. J. Immunol. 28:2714.
17. Suda, T., and S. Nagata. 1994. Purification and characterization of the Fas-ligand that induces apoptosis. J. Exp. Med. 179:873.
18. Tanaka, M., T. Suda, T. Takahashi, and S. Nagata. 1995. Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J. 14:1129.
19. Kayagaki, N., A. Kawasaki, T. Ebata, H. Ohmoto, S. Ikeda, S. Inoue, K. Yoshino, K. Okumura, and H. Yagita. 1995. Metalloproteinase-mediated release of human Fas ligand. J. Exp. Med. 182:1777.
20. Mariani, S. M., B. Matiba, C. Bäumler, and P. H. Krammer. 1995. Regulation of cell surface APO-1/Fas(CD95) ligand expression by metaloproteases. Eur. J. Immunol. 25:2303.
21. Tanaka, M., T. Suda, K. Haze, N. Nakamura, K. Sato, F. Kimura, K. Motoyoshi, M. Mizuki, S. Tagawa, S. Ohga, et al. 1996. Fas ligand in human serum. Nat. Med. 2:317.
22. Martínez-Lorenzo, M. J., M. A. Alava, A. Anel, A. Piñeiro, and J. Naval. 1996. Release of preformed Fas ligand in soluble form is the major factor for activation-induced death of Jurkat T cells. Immunology 89:511.
23. Anel, A., J. Naval, B. González, J. M. Torres, Z. Mishal, J. Uriel, and A. Piñeiro. 1990. Fatty acid metabolism in human lymphocytes. I. Time-course changes in fatty acid composition and membrane fluidity during blastic transformation of peripheral blood lymphocytes. Biochim. Biophys. Acta 1044:323.
24. Alley, M. C., D. A. Scudiero, A. Monks, M. L. Hursey, M. J. Czerwinski, D. Fine, B. J. Abbot, J. G. Mayo, R. H. Shoemaker, and M. R. Boyd. 1988. Sensibility of drug screening with panels of human tumor cell lines using microculture tetrazolium assay. Cancer Res. 46:589.
25. Anel, A., J. Naval, P. Desportes, B. Gonzalez, J. Uriel, and A. Piñeiro. 1992. Increased cytotoxicity of polyunsaturated fatty acids on human tumoral B and T-cell lines compared with normal lymphocytes. Leukemia 6:680.
26. Susin, S. A., N. Zamzami, M. Castedo, E. Daugas, H. G. Wang, S. Geley, F. Fassy, J. C. Reed, and G. Kroemer. 1997. The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/APO-1/CD95-and ceramide-induced apoptosis. J. Exp. Med. 186:25.
27. Parr, E. J., E. B. Myles, M. Hanani, D. Seror, K. T. Riabowol, and K. A. Sharkey. 1997. Immunoreactivity for the Fas ligand in the mammalian enteric nervous system. Cell Tissue Res. 290:21.
28. Gamen, S., A. Anel, A. Piñeiro, and J. Naval. 1998. Caspases are the main executoniers of Fas-mediated apoptosis, irrespective of the ceramide-signaling pathway. Cell Death Differ. 5:241.
29. Robinson, R. A., L. Worfolk, and P. B. Tracy. 1992. Endotoxin enhances the expression of monocyte prothrombinase activity. Blood 79:406.
30. Malecki, M., and H. Ris. 1992. Surface topography and intracellular organization of human cells in suspension as revealed by scanning electron microscopy. Scanning 14:76.
31. Bossi, G., and G. M. Griffiths. 1999. Degradation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells. Nat. Med. 5:90.
32. Sims, P. J., E. M. Faioni, T. Wiedmer, and S. J. Shattil. 1988. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J. Biol. Chem. 263:18205.
33. Raposo, G., H. W. Nijman, W. Stoorvogel, R. Leijendekker, C. V. Harding, C. J. M. Melief, and H. J. Geuze. 1996. B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183:1161.
34. Zitvogel, L., A. Regnault, A. Lozier, J. Wolfers, C. Flament, D. Tenza, P. Ricciardi-Castagnoli, G. Raposo, and S. Amigorena. 1998. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat. Med. 4:594.
35. Yano, Y., J. I. Kambayashi, E. Shiba, M. Sakon, E. Oiki, K. Fukuda, T. Kawasaki, and T. Mori. 1994. The role of protein phosphorylation and cytoskeletal reorganization in microparticle formation from the platelet plasma membrane. Biochem. J. 299:303.
36. Irmler, M., M. Thome, M. Hahne, P. Schneider, K. Hofmann, V. Steiner, J. L. Bodmer, M. Schröter, K. Burns, C. Mattmann, et al. 1997. Inhibition of death receptor signals by cellular FLIP. Nature 388:190.
37. Rudel, T., and G. M. Bokoch. 1997. Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science 276: 1571.
38. Peter, M. E., F. C. Kischkel, C. G. Scheuerpflug, J. P. Medema, K. M. Debatin, and P. H. Krammer. 1997. Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/ caspase 8) to the CD95 death-inducing signalling complex. Eur. J. Immunol. 27:1207.
39. Casciola-Rosen, L., G. Anhalt, and A. Rosen. 1994. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med 179:1317.
40. Suda, T., H. Hashimoto, M. Tanaka, T. Ochi, and S. Nagata. 1997. Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing. J. Exp. Med. 186:2045.
41. Tanaka, M., T. Itai, M. Adachi, and S. Nagata. 1998. Downregulation of Fas ligand by shedding. Nat. Med. 4:31.
42. Schneider, P., N. Holler, J. L. Bodmer, M. Hahne, K. Frei, A. Fontana, and J. Tschopp. 1998. Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J. Exp. Med. 187:1205.
43. Albanese, J., S. Meterissian, M. Kontogiannea, C. Dubreuil, A. Hand, S. Sorba, and N. Dainiak. 1998. Biologically active Fas antigen and its cognate ligand are expressed on plasma membrane-derived extracellular vesicles. Blood 91:3862.
44. Monks, C. R. F., B. A. Freiberg, H. Kupfer, N. Sciaky, and A. Kupfer. 1998. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 395:82.
45. 2+-induced microvesiculation and deficient expression of procoagulant activity in erythrocytes from a patient with a bleeding disorder: a study of the red blood cells of Scott syndrome. Blood 79:380.
46. Peters, P. J., J. Borst, V. Oorschot, M. Fukuda, O. Krähenbühl, J. Tschopp, J. W. Slot, and H. J. Geuze. 1991. Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perform and granzymes. J. Exp. Med. 173:1099.
47. Griffiths, G. M. 1996. Secretory lysosomes: a special mechanism of regulated secretion in hematopoietic cells. Trends Cell Biol. 6:329.